Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1253560

Stable gastric pentadecapeptide BPC 157 therapy of rat glaucoma


Kralj, Tamara; Kokot, Antonio; Zlatar, Mirna; Masnec, Sanja; Kašnik Kovač, Katarina; Milković Periša, Marija; Batelja Vuletić, Lovorka; Giljanović, Ana; Štrbe, Sanja; Sikirić, Sunčana et al.
Stable gastric pentadecapeptide BPC 157 therapy of rat glaucoma // Biomedicines, 10 (2021), 1; 89, 26 doi:10.3390/biomedicines10010089 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1253560 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Stable gastric pentadecapeptide BPC 157 therapy of rat glaucoma

Autori
Kralj, Tamara ; Kokot, Antonio ; Zlatar, Mirna ; Masnec, Sanja ; Kašnik Kovač, Katarina ; Milković Periša, Marija ; Batelja Vuletić, Lovorka ; Giljanović, Ana ; Štrbe, Sanja ; Sikirić, Sunčana ; Balog, Slaven ; Sontacchi, Bojan ; Sontacchi, Dijana ; Buljan, Matko ; Lovrić, Eva ; Boban Blagaić, Alenka ; Škrtić, Anita ; Seiwerth, Sven ; Sikirić, Predrag

Izvornik
Biomedicines (2227-9059) 10 (2021), 1; 89, 26

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
glaucoma ; pentadecapeptide BPC 157 ; rat ; therapy

Sažetak
Cauterization of three episcleral veins (open- angle glaucoma model) induces venous congestion and increases intraocular pressure in rats. If not upgraded, one episcleral vein is regularly unable to acquire and take over the whole function, and glaucoma-like features persist. Recently, the rapid upgrading of the collateral pathways by a stable gastric pentadecapeptide BPC 157 has cured many severe syndromes induced by permanent occlusion of major vessels, veins and/or arteries, peripherally and centrally. In a six-week study, medication was given prophylactically (immediately before glaucoma surgery, i.e., three episcleral veins cauterization) or as curative treatment (starting at 24 h after glaucoma surgery). The daily regimen of BPC 157 (0.4 µg/eye, 0.4 ng/eye ; 10 µg/kg, 10 ng/kg) was administered locally as drops in each eye, intraperitoneally (last application at 24 h before sacrifice) or per- orally in drinking water (0.16 µg/mL, 0.16 ng/mL, 12 mL/rat until the sacrifice, first application being intragastric). Consequently, all BPC 157 regimens immediately normalized intraocular pressure. BPC 157-treated rats exhibited normal pupil diameter, microscopically well-preserved ganglion cells and optic nerve presentation, normal fundus presentation, normal retinal and choroidal blood vessel presentation and normal optic nerve presentation. As leading symptoms, increased intraocular pressure and mydriasis, as well as degeneration of retinal ganglion cells, optic nerve head excavation and reduction in optic nerve thickness, generalized severe irregularity of retinal vessels, faint presentation of choroidal vessels and severe optic nerve disc atrophy were all counteracted. In conclusion, we claim that the reversal of the episcleral veins cauterization glaucoma appeared as a consequence of the BPC 157 therapy of the vessel occlusion- induced perilous syndrome.

Izvorni jezik
Engleski

Znanstvena područja
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)



POVEZANOST RADA


Ustanove:
Medicinski fakultet, Zagreb,
Medicinski fakultet, Osijek

Poveznice na cjeloviti tekst rada:

doi pubmed.ncbi.nlm.nih.gov

Citiraj ovu publikaciju:

Kralj, Tamara; Kokot, Antonio; Zlatar, Mirna; Masnec, Sanja; Kašnik Kovač, Katarina; Milković Periša, Marija; Batelja Vuletić, Lovorka; Giljanović, Ana; Štrbe, Sanja; Sikirić, Sunčana et al.
Stable gastric pentadecapeptide BPC 157 therapy of rat glaucoma // Biomedicines, 10 (2021), 1; 89, 26 doi:10.3390/biomedicines10010089 (međunarodna recenzija, članak, znanstveni)
Kralj, T., Kokot, A., Zlatar, M., Masnec, S., Kašnik Kovač, K., Milković Periša, M., Batelja Vuletić, L., Giljanović, A., Štrbe, S. & Sikirić, S. (2021) Stable gastric pentadecapeptide BPC 157 therapy of rat glaucoma. Biomedicines, 10 (1), 89, 26 doi:10.3390/biomedicines10010089.
@article{article, author = {Kralj, Tamara and Kokot, Antonio and Zlatar, Mirna and Masnec, Sanja and Ka\v{s}nik Kova\v{c}, Katarina and Milkovi\'{c} Peri\v{s}a, Marija and Batelja Vuleti\'{c}, Lovorka and Giljanovi\'{c}, Ana and \v{S}trbe, Sanja and Sikiri\'{c}, Sun\v{c}ana and Balog, Slaven and Sontacchi, Bojan and Sontacchi, Dijana and Buljan, Matko and Lovri\'{c}, Eva and Boban Blagai\'{c}, Alenka and \v{S}krti\'{c}, Anita and Seiwerth, Sven and Sikiri\'{c}, Predrag}, year = {2021}, pages = {26}, DOI = {10.3390/biomedicines10010089}, chapter = {89}, keywords = {glaucoma, pentadecapeptide BPC 157, rat, therapy}, journal = {Biomedicines}, doi = {10.3390/biomedicines10010089}, volume = {10}, number = {1}, issn = {2227-9059}, title = {Stable gastric pentadecapeptide BPC 157 therapy of rat glaucoma}, keyword = {glaucoma, pentadecapeptide BPC 157, rat, therapy}, chapternumber = {89} }
@article{article, author = {Kralj, Tamara and Kokot, Antonio and Zlatar, Mirna and Masnec, Sanja and Ka\v{s}nik Kova\v{c}, Katarina and Milkovi\'{c} Peri\v{s}a, Marija and Batelja Vuleti\'{c}, Lovorka and Giljanovi\'{c}, Ana and \v{S}trbe, Sanja and Sikiri\'{c}, Sun\v{c}ana and Balog, Slaven and Sontacchi, Bojan and Sontacchi, Dijana and Buljan, Matko and Lovri\'{c}, Eva and Boban Blagai\'{c}, Alenka and \v{S}krti\'{c}, Anita and Seiwerth, Sven and Sikiri\'{c}, Predrag}, year = {2021}, pages = {26}, DOI = {10.3390/biomedicines10010089}, chapter = {89}, keywords = {glaucoma, pentadecapeptide BPC 157, rat, therapy}, journal = {Biomedicines}, doi = {10.3390/biomedicines10010089}, volume = {10}, number = {1}, issn = {2227-9059}, title = {Stable gastric pentadecapeptide BPC 157 therapy of rat glaucoma}, keyword = {glaucoma, pentadecapeptide BPC 157, rat, therapy}, chapternumber = {89} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font